251 – 260 of 2796
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Response to “Comment on ‘Maternal Exposure to Per-and Polyfluoroalkyl Substances (PFAS) and Male Reproductive Function in Young Adulthood : Combined Exposure to Seven PFAS’”
- Contribution to journal › Letter
-
Mark
Re : Alexander Cox, Niklas Klümper, Johannes Stein, et al. Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.03.020
- Contribution to journal › Letter
-
Mark
Inledning
- Contribution to journal › Letter
-
Mark
Risk assessment in pulmonary arterial hypertension : A step towards clinical implementation based on the 2022 ESC/ERS pulmonary hypertension guidelines
- Contribution to journal › Letter
-
Mark
Rare-variant collapsing and bioinformatic analyses for amyloidosis, dementia and Parkinson’s disease in the UK biobank reveal novel susceptibility loci
- Contribution to journal › Letter
-
Mark
Nya publikationer
- Contribution to journal › Letter
-
Mark
Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries : EARCO international registry
- Contribution to journal › Letter
-
Mark
Reply : Pretreatment with unfractionated heparin in patients undergoing primary PCI: a standard of treatment together with DAPT?
(2023) In EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 18(17). p.1473-1474
- Contribution to journal › Letter
-
Mark
Validation of clinical prediction scores for pediatric appendicitis - update with new cutoff values for the AIR2 score
- Contribution to journal › Letter
-
Mark
Modelling why 70 per cent of the world's population lack access to surgery
- Contribution to journal › Letter
